Item 9 Labs Corp. ( INLB) - Stock Earnings
INLB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Dec. 2, 2026, midnight | — / — | — | — / — | — |
INLB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -3.2 million USD | 5.0 million USD |
| 2023Q1 | -3.4 million USD | 5.7 million USD |
| 2023Q2 | -5.9 million USD | 5.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INLB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | -12.3 million USD | 8.1 million USD |
| 2021 | -10.9 million USD | 21.9 million USD |
| 2022 | -31.1 million USD | 21.8 million USD |
| 2024 Est. | — | — |
INLB
Price: $0
52 week price:
Earnings Per Share: -0.33 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 70181